Total Payments
$69,973
2024 Payments
$7,485
Companies
54
Transactions
1,028
Medicare Patients
6,455
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$53,068 (75.8%)
Food & Beverage$16,448 (23.5%)
Travel$329.32 (0.5%)
Education$127.92 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,068 | 65 | 75.8% |
| Food and Beverage | $16,448 | 950 | 23.5% |
| Travel and Lodging | $329.32 | 11 | 0.5% |
| Education | $127.92 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $49,692 | 195 | $0 (2024) |
| Allergan, Inc. | $6,435 | 42 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,583 | 103 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $986.80 | 55 | $0 (2024) |
| SK Life Science, Inc. | $787.68 | 31 | $0 (2024) |
| UCB, Inc. | $757.38 | 41 | $0 (2024) |
| Amgen Inc. | $733.33 | 40 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $674.90 | 43 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $622.49 | 26 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $611.73 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,485 | 116 | ABBVIE INC. ($5,926) |
| 2023 | $12,495 | 149 | ABBVIE INC. ($10,370) |
| 2022 | $17,931 | 179 | ABBVIE INC. ($15,795) |
| 2021 | $20,033 | 143 | AbbVie Inc. ($17,576) |
| 2020 | $6,996 | 113 | Allergan, Inc. ($5,397) |
| 2019 | $1,777 | 116 | Novartis Pharmaceuticals Corporation ($246.37) |
| 2018 | $1,834 | 112 | Teva Pharmaceuticals USA, Inc. ($319.03) |
| 2017 | $1,420 | 100 | Teva Pharmaceuticals USA, Inc. ($270.44) |
All Payment Transactions
1,028 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: Neurology | ||||||
| 12/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Neurology | ||||||
| 12/04/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: PAIN | ||||||
| 11/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.09 | General |
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Central Nervous System | ||||||
| 10/22/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Neurology | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,737 | 2,147 | $690,788 | $276,055 |
| 2022 | 17 | 1,720 | 2,143 | $732,090 | $304,358 |
| 2021 | 19 | 1,506 | 1,799 | $609,352 | $258,615 |
| 2020 | 18 | 1,492 | 1,791 | $486,247 | $204,151 |
Total Patients
6,455
Total Services
7,880
Medicare Billing
$1.0M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 480 | 713 | $139,035 | $64,136 | 46.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 77 | 81 | $100,764 | $37,191 | 36.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 89 | 89 | $78,231 | $29,053 | 37.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 60 | 60 | $71,460 | $26,325 | 36.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 195 | 273 | $52,416 | $20,384 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 159 | 159 | $39,273 | $17,756 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 94 | 112 | $30,464 | $14,383 | 47.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 74 | 75 | $34,200 | $11,980 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 175 | $23,975 | $10,333 | 43.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $20,100 | $9,535 | 47.4% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 127 | 190 | $24,510 | $8,393 | 34.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 53 | 53 | $20,193 | $7,007 | 34.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 31 | 32 | $16,704 | $6,053 | 36.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 21 | 21 | $15,414 | $5,964 | 38.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 23 | 23 | $13,869 | $4,964 | 35.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 20 | 20 | $5,780 | $2,026 | 35.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 11 | 11 | $4,400 | $569.60 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 470 | 745 | $145,275 | $70,561 | 48.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 86 | 94 | $116,936 | $45,568 | 39.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 84 | 84 | $100,044 | $37,584 | 37.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 86 | 87 | $76,473 | $28,970 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 163 | 163 | $40,261 | $19,587 | 48.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 179 | 246 | $47,232 | $19,088 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 189 | 196 | $26,852 | $12,470 | 46.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 39 | 39 | $28,626 | $11,280 | 39.4% |
About Dr. Roman Kesler, DO
Dr. Roman Kesler, DO is a Neurology healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730163114.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roman Kesler, DO has received a total of $69,973 in payments from pharmaceutical and medical device companies, with $7,485 received in 2024. These payments were reported across 1,028 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($53,068).
As a Medicare-enrolled provider, Kesler has provided services to 6,455 Medicare beneficiaries, totaling 7,880 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine
- Location Pensacola, FL
- Active Since 11/30/2005
- Last Updated 04/18/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730163114
Products in Payments
- UBRELVY (Drug) $41,843
- QULIPTA (Drug) $12,944
- BOTOX (Biological) $862.25
- Aimovig (Biological) $631.58
- NURTEC ODT (Drug) $554.47
- TROKENDI XR (Drug) $548.85
- APTIOM (Drug) $533.19
- AUSTEDO (Drug) $511.81
- AIMOVIG (Biological) $508.17
- XYWAV (Drug) $495.33
- COPAXONE (Drug) $377.22
- NUEDEXTA (Drug) $373.16
- VYEPTI (Biological) $371.70
- Fycompa (Drug) $370.21
- DUOPA (Drug) $357.61
- GOCOVRI (Drug) $343.81
- RYTARY (Drug) $322.59
- AJOVY (Biological) $310.00
- KESIMPTA (Drug) $308.30
- Briviact (Drug) $299.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Pensacola
David Bear, D.o, D.O
Neurology — Payments: $585,571
Neurology $585,571
Dr. Ethan Gore, M.d, M.D
Neurology — Payments: $47,830
Neurology $47,830
Dr. Henry Porter, M.d, M.D
Neurology — Payments: $40,702
Neurology $40,702
Dr. Lawrence King, M.d, M.D
Neurology — Payments: $36,925
Neurology $36,925
George Dmytrenko, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $33,531
Neurology $33,531
Daniel Ross, D.o, D.O
Neurology — Payments: $27,982
Neurology $27,982